Regeneron Pharmaceuticals Inc banner

Regeneron Pharmaceuticals Inc
LSE:0R2M

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
LSE:0R2M
Watchlist
Price: 714.16 USD 0.61% Market Closed
Market Cap: $75.1B

Intrinsic Value

The intrinsic value for Regeneron Pharmaceuticals Inc (0R2M) under the Base Case is 761.68 USD. Compared with the current market price of 714.16 USD, the stock appears Undervalued by 6% .

Based on two methods:

Both DCF and multiples point to undervaluation.

0R2M Intrinsic Value
761.68 USD
Undervaluation 6%
Intrinsic Value
Price $714.16
Bear Case
Base Case
Bull Case
Monitor 0R2M
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $609.35
Get notified when the price drops into your buy zone
Intrinsic Value $761.68
Current Price $714.16
Margin of Safety 20% $609.35
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 0R2M?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0R2M valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Regeneron Pharmaceuticals Inc.

Explain Valuation
Alternatives to 0R2M

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

REGN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 0R2M stock?

The intrinsic value for Regeneron Pharmaceuticals Inc (0R2M) under the Base Case is 761.68 USD.

Is 0R2M stock undervalued or overvalued?

Compared with the current market price of 714.16 USD, the stock appears Undervalued by 6% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett